Identification of New Cytotoxic T-Cell Epitopes on the 38-Kilodalton Lipoglycoprotein of Mycobacterium tuberculosis by Using Lipopeptides
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the...
Saved in:
Published in | Infection and Immunity Vol. 66; no. 7; pp. 3190 - 3197 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.07.1998
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Classifications
Services
IAI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
IAI
About
IAI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
Connect to IAI
IAI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0019-9567
Online ISSN:
1098-5522
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
IAI
.asm.org, visit:
IAI
|
---|---|
AbstractList | Induction of cytotoxic T lymphocytes (CTLs) by vaccination has been shown to protect against bacterial, viral, and tumoral challenge. The aim of this study was to identify CTL epitopes on the 38-kDa lipoglycoprotein from Mycobacterium tuberculosis. The identification of these CTL epitopes was based on synthesizing peptides designed from the 38-kDa lipoglycoprotein, with known major histocompatibility complex class I (MHC-I) binding motifs (H-2D super(b)), and studying their ability to up-regulate and stabilize MHC-I molecules on the mouse lymphoma cell line RMA-S. To improve the capacity of the identified peptides to induce CTL responses in mice, palmitic acid with a cysteine-serine-serine spacer amino acid sequence was attached to the amino terminus of the peptide. Two of five peptides with H-2D super(b) binding motifs and their corresponding lipopeptides up-regulated and stabilized the H-2D super(b) molecules on RMA-S cells. Both lipopeptides, in combination with incomplete Freund's adjuvant, induced CTL responses in C57BL/6 (H-2 super(b)) mice. Moreover, the lipopeptide induced stronger CTL responses than the peptide. The capacity of the various lipopeptides to induce CTL displayed a good relationship with the ability of the (lipo)peptide to up-regulate and to stabilize H-2D super(b) molecules. The capacity of the peptides and lipopeptides to up-regulate and stabilize MHC-I expression can therefore be used to predict their potential to function as a CTL epitope. The newly identified CTL epitopes and their lipid derivatives provide us with important information for future M. tuberculosis vaccine design. Induction of cytotoxic T lymphocytes (CTLs) by vaccination has been shown to protect against bacterial, viral, and tumoral challenge. The aim of this study was to identify CTL epitopes on the 38-kDa lipoglycoprotein from Mycobacterium tuberculosis . The identification of these CTL epitopes was based on synthesizing peptides designed from the 38-kDa lipoglycoprotein, with known major histocompatibility complex class I (MHC-I) binding motifs (H-2D b ), and studying their ability to up-regulate and stabilize MHC-I molecules on the mouse lymphoma cell line RMA-S. To improve the capacity of the identified peptides to induce CTL responses in mice, palmitic acid with a cysteine-serine-serine spacer amino acid sequence was attached to the amino terminus of the peptide. Two of five peptides with H-2D b binding motifs and their corresponding lipopeptides up-regulated and stabilized the H-2D b molecules on RMA-S cells. Both lipopeptides, in combination with incomplete Freund’s adjuvant, induced CTL responses in C57BL/6 (H-2 b ) mice. Moreover, the lipopeptide induced stronger CTL responses than the peptide. The capacity of the various lipopeptides to induce CTL displayed a good relationship with the ability of the (lipo)peptide to up-regulate and to stabilize H-2D b molecules. The capacity of the peptides and lipopeptides to up-regulate and stabilize MHC-I expression can therefore be used to predict their potential to function as a CTL epitope. The newly identified CTL epitopes and their lipid derivatives provide us with important information for future M. tuberculosis vaccine design. Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology. For an alternate route to IAI .asm.org, visit: IAI Induction of cytotoxic T lymphocytes (CTLs) by vaccination has been shown to protect against bacterial, viral, and tumoral challenge. The aim of this study was to identify CTL epitopes on the 38-kDa lipoglycoprotein from Mycobacterium tuberculosis. The identification of these CTL epitopes was based on synthesizing peptides designed from the 38-kDa lipoglycoprotein, with known major histocompatibility complex class I (MHC-I) binding motifs (H-2Db), and studying their ability to up-regulate and stabilize MHC-I molecules on the mouse lymphoma cell line RMA-S. To improve the capacity of the identified peptides to induce CTL responses in mice, palmitic acid with a cysteine-serine-serine spacer amino acid sequence was attached to the amino terminus of the peptide. Two of five peptides with H-2Db binding motifs and their corresponding lipopeptides up-regulated and stabilized the H-2Db molecules on RMA-S cells. Both lipopeptides, in combination with incomplete Freund's adjuvant, induced CTL responses in C57BL/6 (H-2(b)) mice. Moreover, the lipopeptide induced stronger CTL responses than the peptide. The capacity of the various lipopeptides to induce CTL displayed a good relationship with the ability of the (lipo)peptide to up-regulate and to stabilize H-2Db molecules. The capacity of the peptides and lipopeptides to up-regulate and stabilize MHC-I expression can therefore be used to predict their potential to function as a CTL epitope. The newly identified CTL epitopes and their lipid derivatives provide us with important information for future M. tuberculosis vaccine design. |
Author | Dianne Joosten Dora P. A. J. da Fonseca Hans M. Vordermeier Danny L. Jue Mahavir Singh André F. M. Verheul Harm Snippe Ruurd van der Zee |
AuthorAffiliation | Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, 1 and Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, 3508 TD Utrecht, 2 The Netherlands; Biotechnology Core Facility, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333 3 ; GBF—German National Research Center for Biotechnology, 38124 Braunschweig, Germany 4 ; and Veterinary Laboratories Agency, Bacteriology, TB Research Group, New Haw, Addlestone, Surrey KT13 3NB, United Kingdom 5 |
AuthorAffiliation_xml | – name: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, 1 and Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, 3508 TD Utrecht, 2 The Netherlands; Biotechnology Core Facility, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333 3 ; GBF—German National Research Center for Biotechnology, 38124 Braunschweig, Germany 4 ; and Veterinary Laboratories Agency, Bacteriology, TB Research Group, New Haw, Addlestone, Surrey KT13 3NB, United Kingdom 5 |
Author_xml | – sequence: 1 givenname: D. P. A. J surname: DA FONSECA fullname: DA FONSECA, D. P. A. J organization: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, Netherlands – sequence: 2 givenname: D surname: JOOSTEN fullname: JOOSTEN, D organization: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, Netherlands – sequence: 3 givenname: R surname: VAN DER ZEE fullname: VAN DER ZEE, R organization: Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, 3508 TD Utrecht, Netherlands – sequence: 4 givenname: D. L surname: JUE fullname: JUE, D. L organization: Biotechnology Core Facility, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, United States – sequence: 5 givenname: M surname: SINGH fullname: SINGH, M organization: GBF-German National Research Center for Biotechnology, 38124 Braunschweig, United Kingdom – sequence: 6 givenname: H. M surname: VORDERMEIER fullname: VORDERMEIER, H. M organization: Veterinary Laboratories Agency, Bacteriology, TB Research Group, New Haw, Addlestone, Surrey KT13 3NB, United Kingdom – sequence: 7 givenname: H surname: SNIPPE fullname: SNIPPE, H organization: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, Netherlands – sequence: 8 givenname: A. F. M surname: VERHEUL fullname: VERHEUL, A. F. M organization: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, Academic Hospital Utrecht, Utrecht University, 3584 CX Utrecht, Netherlands |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2323208$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9632585$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUcuO0zAUtdCgoTPwCQgjIXYJdpw49oLFqBqgosBmZm35ldYoiYPtMPQT-GucaVXBis21rs_DvvdcgYvRjxaAVxiVGFfs3eZmU1JatiXBHBW5tCXmnD0BK4w4K5qmqi7ACiHMC97Q9hm4ivF7buu6ZpfgklNSNaxZgd8bY8fkOqdlcn6EvoNf7QNcH5JP_pfT8K5Y276Ht5NLfrIRZk7aW0hY8dn13sg-5Zutm_yuP2g_BZ-se7T5klsldbLBzQNMs7JBz72PLkJ1gPfRjbtH3WSn5IyNz8HTTvbRvjid1-D-w-3d-lOx_fZxs77ZFromdSpUTZhRWknDOdGN5IxaYw1RXElpFFZUUUwIyiivZOYSUiMpmbat1LVR5Bq8P_pOsxqs0Xn8IHsxBTfIcBBeOvEvMrq92PmfAiNGSJX1b0_64H_MNiYxuKjzjuRo_RxFy3mDMW3-S8QtRjUnLBPbI1EHH2Ow3fkzGIklbZHTFpSKVixpL6UVS9pZ-fLvWc66U7wZf3PCZdSy74IctYtnWpXHqdBi8_pI27vd_sEFK2QchMubOD9K_gCf6MTP |
CODEN | INFIBR |
CitedBy_id | crossref_primary_10_1016_S0264_410X_01_00265_1 crossref_primary_10_1016_j_pep_2005_12_007 crossref_primary_10_1128_IAI_69_8_4839_4845_2001 crossref_primary_10_1111_j_1365_3083_2006_01815_x crossref_primary_10_1089_027245700315761 crossref_primary_10_1189_jlb_0403138 crossref_primary_10_4049_jimmunol_165_1_353 crossref_primary_10_1046_j_1440_1711_2000_00936_x crossref_primary_10_1021_mp700126c crossref_primary_10_1089_omi_2007_0037 crossref_primary_10_2217_bmm_11_79 crossref_primary_10_4049_jimmunol_180_5_3436 crossref_primary_10_3389_fimmu_2022_830497 crossref_primary_10_1016_j_micinf_2009_04_025 crossref_primary_10_1016_S0264_410X_00_00102_X crossref_primary_10_1128_IAI_69_11_6633_6642_2001 crossref_primary_10_1016_j_tim_2021_04_010 crossref_primary_10_1016_S0161_5890_00_00066_3 crossref_primary_10_4049_jimmunol_168_4_1869 crossref_primary_10_1099_jmm_0_46928_0 crossref_primary_10_1016_j_intimp_2021_107441 crossref_primary_10_1016_S0264_410X_03_00513_9 crossref_primary_10_1111_j_1348_0421_2000_tb02592_x |
Cites_doi | 10.1002/eji.1830230929 10.1002/eji.1830201219 10.1073/pnas.89.24.12013 10.1002/eji.1830221024 10.1016/0952-7915(94)90028-0 10.1038/nm0896-888 10.1046/j.1365-3083.1997.d01-432.x 10.1002/eji.1830180110 10.1111/j.1399-3011.1992.tb00299.x 10.1093/intimm/5.11.1489 10.1038/346476a0 10.1016/0167-5699(88)91292-3 10.1046/j.1365-3083.1996.d01-340.x 10.4049/jimmunol.148.6.1871 10.1002/eji.1830211102 10.4049/jimmunol.153.12.5586 10.1016/0092-8674(93)90472-3 10.4049/jimmunol.147.3.1023 10.1084/jem.176.6.1611 10.1002/eji.1830250431 10.1038/342561a0 10.1016/0923-2508(91)90097-T 10.1002/eji.1830221209 10.1038/361359a0 10.1111/j.1365-2362.1995.tb01716.x 10.1126/science.257.5073.1055 10.4049/jimmunol.158.12.5921 10.1016/0161-5890(94)90155-4 10.1016/0264-410X(95)00084-E 10.1093/intimm/7.4.559 10.4049/jimmunol.156.11.4182 10.1002/eji.1830181203 10.1378/chest.103.6.1641 10.1016/0264-410X(89)90007-8 10.1046/j.1365-2567.1996.512590.x 10.4049/jimmunol.149.10.3416 10.1128/iai.54.1.177-183.1986 10.1016/0022-1759(92)90322-K 10.1002/j.2326-1951.1993.tb03118.x 10.1016/0022-1759(95)00052-C 10.1093/intimm/9.11.1669 10.1002/eji.1830250637 10.1016/0264-410X(95)93320-9 10.1038/341323a0 |
ContentType | Journal Article |
Copyright | 1998 INIST-CNRS Copyright © 1998, American Society for Microbiology 1998 |
Copyright_xml | – notice: 1998 INIST-CNRS – notice: Copyright © 1998, American Society for Microbiology 1998 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7X8 5PM |
DOI | 10.1128/IAI.66.7.3190-3197.1998 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-5522 |
EndPage | 3197 |
ExternalDocumentID | 10_1128_IAI_66_7_3190_3197_1998 9632585 2323208 iai_66_7_3190 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X .55 .GJ 08R 0R~ 18M 29I 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 85S AAPBV AAUGY ABOCM ACGFO ADBBV AENEX AFMIJ AGCDD AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CS3 D0S DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ H~9 IH2 IQODW J5H KQ8 L7B MVM NEJ O9- OHT OK1 P2P RHF RHI RNS RPM RSF SJN TR2 TWZ UCJ UPT VH1 VQA W2D W8F WH7 WHG WOQ X7M XFK Y6R ZA5 ZGI ZXP ~KM AGVNZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7X8 5PM |
ID | FETCH-LOGICAL-c434t-b438dbcbad993c5a986eded3b9baadb1b6b6133099392a38d3340aa8ce7ac4db3 |
IEDL.DBID | RPM |
ISSN | 0019-9567 |
IngestDate | Tue Sep 17 20:54:58 EDT 2024 Fri Oct 25 03:02:57 EDT 2024 Fri Oct 25 09:24:56 EDT 2024 Fri Dec 06 06:27:08 EST 2024 Sat Sep 28 07:41:07 EDT 2024 Sun Oct 29 17:06:48 EDT 2023 Wed May 18 15:27:12 EDT 2016 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Antigenic determinant Major histocompatibility system Cytotoxicity Cellular immunity H-2-System Specificity Immunogenicity Mycobacterium tuberculosis Mycobacteriales T-Lymphocyte Mycobacteriaceae Bacteria Actinomycetes Class I histocompatibility antigen Lipopeptide |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c434t-b438dbcbad993c5a986eded3b9baadb1b6b6133099392a38d3340aa8ce7ac4db3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Editor: R. N. Moore Corresponding author. Mailing address: Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, Section Vaccines, AZU, Rm. G04.614, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Phone: 31-30-2506525. Fax: 31-30-2541770. E-mail: D.Fonseca@lab.azu.nl. |
PMID | 9632585 |
PQID | 17104938 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | crossref_primary_10_1128_IAI_66_7_3190_3197_1998 pubmed_primary_9632585 pubmedcentral_primary_oai_pubmedcentral_nih_gov_108332 proquest_miscellaneous_17104938 proquest_miscellaneous_79951165 highwire_asm_iai_66_7_3190 pascalfrancis_primary_2323208 |
PublicationCentury | 1900 |
PublicationDate | 1998-07-01 |
PublicationDateYYYYMMDD | 1998-07-01 |
PublicationDate_xml | – month: 07 year: 1998 text: 1998-07-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Infection and Immunity |
PublicationTitleAlternate | Infect Immun |
PublicationYear | 1998 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | 7513522 - Curr Opin Immunol. 1994 Feb;6(1):13-23 1281212 - J Exp Med. 1992 Dec 1;176(6):1611-8 2470215 - Vaccine. 1989 Feb;7(1):29-33 7537671 - Eur J Immunol. 1995 Apr;25(4):1063-70 7540640 - J Immunol Methods. 1995 Jun 9;182(2):219-26 1517589 - J Immunol Methods. 1992 Aug 30;153(1-2):193-200 1906192 - Res Microbiol. 1991 Jan;142(1):55-65 1282504 - Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):255-60 1446701 - Eur J Immunol. 1992 Dec;22(12):3085-90 1396968 - Eur J Immunol. 1992 Oct;22(10):2631-7 2428751 - Infect Immun. 1986 Oct;54(1):177-83 2586628 - Nature. 1989 Nov 30;342(6249):561-4 1936113 - Eur J Immunol. 1991 Nov;21(11):2649-54 7527444 - J Immunol. 1994 Dec 15;153(12):5586-92 7823965 - Mol Immunol. 1994 Dec;31(18):1391-401 7656913 - Eur J Clin Invest. 1995 Jun;25(6):371-7 8778016 - Immunology. 1996 Mar;87(3):339-42 2477703 - Nature. 1989 Sep 28;341(6240):323-6 1385524 - J Immunol. 1992 Nov 15;149(10):3416-22 8947600 - Scand J Immunol. 1996 Nov;44(5):485-92 7505110 - Int Immunol. 1993 Nov;5(11):1489-92 1465432 - Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013-7 8404075 - Chest. 1993 Jun;103(6):1641-2 1509256 - Science. 1992 Aug 21;257(5073):1055-64 7678924 - Nature. 1993 Jan 28;361(6410):359-62 9190945 - J Immunol. 1997 Jun 15;158(12):5921-6 1541825 - J Immunol. 1992 Mar 15;148(6):1871-8 7547682 - Int Immunol. 1995 Apr;7(4):559-66 8578845 - Vaccine. 1995 Nov;13(16):1576-82 9160097 - Scand J Immunol. 1997 May;45(5):521-6 2269329 - Eur J Immunol. 1990 Dec;20(12):2651-9 2198471 - Nature. 1990 Aug 2;346(6283):476-80 7631520 - Vaccine. 1995 Feb;13(3):313-20 3146508 - Eur J Immunol. 1988 Dec;18(12):1881-7 1705236 - Immunology. 1991 Jan;72(1):109-13 7690326 - Eur J Immunol. 1993 Sep;23(9):2242-9 8104103 - Cell. 1993 Sep 10;74(5):929-37 8666786 - J Immunol. 1996 Jun 1;156(11):4182-90 7615001 - Eur J Immunol. 1995 Jun;25(6):1739-43 2450033 - Eur J Immunol. 1988 Jan;18(1):59-66 3151440 - Immunol Today. 1988 Jun;9(6):168-74 1713602 - J Immunol. 1991 Aug 1;147(3):1023-9 8705858 - Nat Med. 1996 Aug;2(8):888-92 9418128 - Int Immunol. 1997 Nov;9(11):1669-76 e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_28_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_46_2 Song R. (e_1_3_2_30_2) 1996; 156 Zhu X. (e_1_3_2_47_2) 1997; 158 Martinon F. (e_1_3_2_19_2) 1992; 149 e_1_3_2_9_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 Weismuller K.-H. (e_1_3_2_41_2) 1991; 72 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 Sette A. (e_1_3_2_29_2) 1994; 153 Vordermeier H. M. (e_1_3_2_35_2) 1991; 147 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 Romero P. (e_1_3_2_25_2) 1992; 148 Kauffman S. H. E. (e_1_3_2_15_2) 1993; 1 |
References_xml | – ident: e_1_3_2_10_2 doi: 10.1002/eji.1830230929 – ident: e_1_3_2_13_2 doi: 10.1002/eji.1830201219 – ident: e_1_3_2_12_2 doi: 10.1073/pnas.89.24.12013 – ident: e_1_3_2_36_2 doi: 10.1002/eji.1830221024 – ident: e_1_3_2_9_2 doi: 10.1016/0952-7915(94)90028-0 – ident: e_1_3_2_32_2 doi: 10.1038/nm0896-888 – ident: e_1_3_2_39_2 doi: 10.1046/j.1365-3083.1997.d01-432.x – ident: e_1_3_2_5_2 doi: 10.1002/eji.1830180110 – volume: 72 start-page: 109 year: 1991 ident: e_1_3_2_41_2 article-title: The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. publication-title: Immunology contributor: fullname: Weismuller K.-H. – ident: e_1_3_2_42_2 doi: 10.1111/j.1399-3011.1992.tb00299.x – ident: e_1_3_2_8_2 doi: 10.1093/intimm/5.11.1489 – ident: e_1_3_2_18_2 doi: 10.1038/346476a0 – ident: e_1_3_2_14_2 doi: 10.1016/0167-5699(88)91292-3 – ident: e_1_3_2_21_2 doi: 10.1046/j.1365-3083.1996.d01-340.x – volume: 148 start-page: 1871 year: 1992 ident: e_1_3_2_25_2 article-title: Immunization with synthetic peptides containing a defined malaria epitope induces highly diverse cytotoxic T lymphocyte responses. publication-title: J. Immunol. doi: 10.4049/jimmunol.148.6.1871 contributor: fullname: Romero P. – ident: e_1_3_2_27_2 doi: 10.1002/eji.1830211102 – volume: 153 start-page: 5586 year: 1994 ident: e_1_3_2_29_2 article-title: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. publication-title: J. Immunol. doi: 10.4049/jimmunol.153.12.5586 contributor: fullname: Sette A. – ident: e_1_3_2_26_2 doi: 10.1016/0092-8674(93)90472-3 – volume: 147 start-page: 1023 year: 1991 ident: e_1_3_2_35_2 article-title: Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. publication-title: J. Immunol. doi: 10.4049/jimmunol.147.3.1023 contributor: fullname: Vordermeier H. M. – ident: e_1_3_2_4_2 doi: 10.1084/jem.176.6.1611 – ident: e_1_3_2_28_2 doi: 10.1002/eji.1830250431 – ident: e_1_3_2_31_2 – ident: e_1_3_2_6_2 doi: 10.1038/342561a0 – ident: e_1_3_2_44_2 doi: 10.1016/0923-2508(91)90097-T – ident: e_1_3_2_45_2 doi: 10.1002/eji.1830221209 – ident: e_1_3_2_22_2 doi: 10.1038/361359a0 – volume: 1 start-page: 109 year: 1993 ident: e_1_3_2_15_2 article-title: Tuberculosis, the role of the immune system. publication-title: Immunologist contributor: fullname: Kauffman S. H. E. – ident: e_1_3_2_20_2 doi: 10.1111/j.1365-2362.1995.tb01716.x – ident: e_1_3_2_3_2 doi: 10.1126/science.257.5073.1055 – volume: 158 start-page: 5921 year: 1997 ident: e_1_3_2_47_2 article-title: Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. publication-title: J. Immunol. doi: 10.4049/jimmunol.158.12.5921 contributor: fullname: Zhu X. – ident: e_1_3_2_11_2 doi: 10.1016/0161-5890(94)90155-4 – ident: e_1_3_2_38_2 doi: 10.1016/0264-410X(95)00084-E – ident: e_1_3_2_37_2 doi: 10.1093/intimm/7.4.559 – volume: 156 start-page: 4182 year: 1996 ident: e_1_3_2_30_2 article-title: Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. publication-title: J. Immunol. doi: 10.4049/jimmunol.156.11.4182 contributor: fullname: Song R. – ident: e_1_3_2_23_2 doi: 10.1002/eji.1830181203 – ident: e_1_3_2_16_2 doi: 10.1378/chest.103.6.1641 – ident: e_1_3_2_40_2 doi: 10.1016/0264-410X(89)90007-8 – ident: e_1_3_2_33_2 doi: 10.1046/j.1365-2567.1996.512590.x – volume: 149 start-page: 3416 year: 1992 ident: e_1_3_2_19_2 article-title: Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. publication-title: J. Immunol. doi: 10.4049/jimmunol.149.10.3416 contributor: fullname: Martinon F. – ident: e_1_3_2_43_2 doi: 10.1128/iai.54.1.177-183.1986 – ident: e_1_3_2_46_2 doi: 10.1016/0022-1759(92)90322-K – ident: e_1_3_2_7_2 doi: 10.1002/j.2326-1951.1993.tb03118.x – ident: e_1_3_2_34_2 doi: 10.1016/0022-1759(95)00052-C – ident: e_1_3_2_48_2 doi: 10.1093/intimm/9.11.1669 – ident: e_1_3_2_2_2 doi: 10.1002/eji.1830250637 – ident: e_1_3_2_17_2 doi: 10.1016/0264-410X(95)93320-9 – ident: e_1_3_2_24_2 doi: 10.1038/341323a0 |
SSID | ssj0014448 |
Score | 1.7088683 |
Snippet | Classifications
Services
IAI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit... Induction of cytotoxic T lymphocytes (CTLs) by vaccination has been shown to protect against bacterial, viral, and tumoral challenge. The aim of this study was... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3190 |
SubjectTerms | Animals Bacteriology Biological and medical sciences Epitopes, T-Lymphocyte Female Fundamental and applied biological sciences. Psychology Glycoproteins - immunology H-2 Antigens - biosynthesis Histocompatibility Antigen H-2D Lipoproteins - immunology Mice Mice, Inbred C57BL Microbial Immunity and Vaccines Microbiology Molecular Weight Mycobacterium tuberculosis Mycobacterium tuberculosis - immunology Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains T-Lymphocytes, Cytotoxic - immunology Tumor Cells, Cultured |
Title | Identification of New Cytotoxic T-Cell Epitopes on the 38-Kilodalton Lipoglycoprotein of Mycobacterium tuberculosis by Using Lipopeptides |
URI | http://iai.asm.org/content/66/7/3190.abstract https://www.ncbi.nlm.nih.gov/pubmed/9632585 https://search.proquest.com/docview/17104938 https://search.proquest.com/docview/79951165 https://pubmed.ncbi.nlm.nih.gov/PMC108332 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVopaJeEBQqUmjxgWt2N7HXSY7VqlWXsohDK_Vm-WMWImWTqEkk9ifwrxknztJFiAOXSJHHlpIZj9_YzzOEfITMJgDxOmQ2NSEicAjTiJnQRmAtLlexBrcPufoibu75p4f5g78U1nhaZWl0PimLzaTMv_fcynpjpiNPbPp1tYgQN7B4ekAOcPUdI3R_csA59943CxH7J57ThW54urxcToSYJBinZs75ZIm7q5cekyO0wnjuyik_XZvGfMGOLqka_GProdTF37Don5TKJ2vU9UvywoNLejl8xCvyDMoTcjSUm9yekOcrf5D-mvwcLuiu_Y4drdYU3R1dbNuqrX7kht6FCygKelXjjK-hoSiDUJGi37rNi8oqV4yafs7r6luxNVWf7SHvh1nhqx5SQHcb2nYaHk1XVE3eUL2lPUOh71c7Oo2F5g25v766W9yEvipDaDjjbag5S602WlmENmauslSABct0ppWyOtJCI0RgiDwReimUZYzPlEoNJMpwq9kpOSyrEt4SimhNWcSLYBXw-cxoDJeEiiBNIFZamIDMRn3Ieki-IfugJU4lKlMKIRPplOkeiXTKDMjZqDepmo3MVf5bLCDne5rcDYqwksUz7Pxh1KzEWeaOTlQJVdfICIEYz9g_JFxiPZfKKCCngyXsBvfGFRCxZyK7dpfge78F7b5P9D3Y-dn_dnxHjocblI5c_J4cto8dnCOEavUFBg_L24t-5vwCTcUfDw |
link.rule.ids | 230,314,727,780,784,885,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagqNALgkLVFEp94JrdTey8jtWq1S7drThspd4sP2YhUjaJmkRif0L_dcd5LF2EOHCJFHlsKZnx-LP9zQwhXyExEYC_dpmJtYsIHNzYY9o1HhiDy5WvwJ5DLm_D2R3_dh_c90FhVU-rzLVKR3m2GeXpz5ZbWW70eOCJjb8vpx7iBuaPX5JXAYsSb9ij93cHnPPe_yYuov-oZ3WhIx7PL-ejMBxFuFNNrPtJIhutFx-RQ7RDP7AFlZ-vTkPGYEuYlBX-s3VX7OJvaPRPUuWzVer6HXnbw0t62X3Ge_IC8mNy2BWc3B6T18v-Kv0DeexCdNf9mR0t1hQdHp1u66IufqWartwpZBm9KnHOl1BRlEGwSNFz3aRZYaQtR00XaVn8yLa6aPM9pO0wS3xVXRLoZkPrRsGDbrKiSiuqtrTlKLT9SkuoMVB9JHfXV6vpzO3rMriaM167irPYKK2kQXCjA5nEIRgwTCVKSqM8FSoECQyxJ4IvibKM8YmUsYZIam4UOyEHeZHDKaGI16RBxAhGAg8mWuGGKZQexBH4UoXaIZNBH6Ls0m-IdtvixwKVKcJQRMIq0z4iYZXpkLNBb0JWG5HK9LeYQ873NLkbFIEl8yfY-WLQrMB5Zi9PZA5FUwkPoRhP2D8kbGo9m8zIISedJewG743LIeGeiezabYrv_Ra0_DbVd2fpZ__b8YK8ma2WC7GY3958IkddPKWlGn8mB_VDA-cIqGr1pZ0_T73RIWs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6Di16GbZuxdKtqw67OoktxY9jkTVo1qbooQV6E_RgNgOObdQOsPyE_etRfmTNMOywiwFDlACbFPVR-kQCfMbERojB0uM2Nh4hcPRinxvP-mgtLVeBRrcPubgNrx7E18fJ4x7E_V2YhrRvdDrMs9UwT7833MpyZUY9T2x0t5j6hBt4MCrtcvQCXk442Vgfp3fnB0KIzgcnHkUAUcfsImc8ml_Mh2E4jChaTZwLSiJ3Yy8-ggOyxWDiiio_X6H6rMGONKkq-m_LtuDF3xDpn8TKZyvV7DW86iAmu2g_5Q3sYX4MB23Ryc0xHC664_S38LO9prvs9u1YsWTk9Nh0Uxd18SM17N6bYpaxy5LmfYkVIxkCjIy813WaFVa5ktTsJi2Lb9nGFE3Oh7QZZkGvuk0EvV6xeq3xyayzokorpjes4Sk0_UpHqrFYvYOH2eX99MrrajN4RnBRe1rw2GqjlSWAYyYqiUO0aLlOtFJW-zrUBBQ44U8CYIpkORdjpWKDkTLCan4C-3mR43tghNmUJdSIVqGYjI2moClUPsYRBkqHZgDjXh-ybFNwyCZ0CWJJypRhKCPplOkekXTKHMBprzepqpVMVfpbbABnO5rcDkrgkgdj6nzea1bSXHMHKCrHYl1Jn-CYSPg_JFx6PZfQaAAnrSVsB--MawDhjols212a790Wsv4m3Xdr7af_2_EcDu--zOTN_Pb6Axy1Vyod2_gj7NdPazwjTFXrT830-QXTjCJ- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+new+cytotoxic+T-cell+epitopes+on+the+38-kilodalton+lipoglycoprotein+of+Mycobacterium+tuberculosis+by+using+lipopeptides&rft.jtitle=Infection+and+immunity&rft.au=da+Fonseca%2C+D+P&rft.au=Joosten%2C+D&rft.au=van+der+Zee%2C+R&rft.au=Jue%2C+D+L&rft.date=1998-07-01&rft.issn=0019-9567&rft.volume=66&rft.issue=7&rft.spage=3190&rft_id=info:doi/10.1128%2FIAI.66.7.3190-3197.1998&rft_id=info%3Apmid%2F9632585&rft.externalDocID=9632585 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon |